Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with ad

Discussion Board › Forums › Chemotherapy & More › Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with ad

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 15, 2019 at 3:04 pm #98565
    gavin
    Moderator

    Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors.

     

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Chemotherapy & More’ is closed to new topics and replies.